Neurochemists study the chemical foundations of brain activity, focusing on the roles of neurotransmitters, receptors, and signaling pathways that influence neural function. Their research helps explain how imbalances in brain chemistry contribute to disorders like depression, schizophrenia, and neurodegenerative diseases such as Parkinson's. Neurochemists investigate the synthesis, release, and recycling of neurotransmitters like dopamine, serotonin, and glutamate, which are key targets for many neurological and psychiatric treatments. Using advanced techniques such as chromatography, mass spectrometry, and molecular assays, they analyze the chemical composition of brain tissue and cerebrospinal fluid, providing critical insights into brain function and dysfunction.
Additionally, neurochemists explore the impact of neuropeptides, oxidative stress, and lipid signaling in processes such as neuroinflammation and neurodegeneration. By collaborating with neuropharmacologists and neurobiologists, they play a pivotal role in designing more effective, targeted therapies with fewer side effects. Their work also includes understanding how lifestyle factors such as diet, environmental exposure, and aging influence brain chemistry, contributing to the field of precision medicine. With this approach, neurochemists are advancing personalized treatment strategies that track and treat neurological conditions with greater accuracy.
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Study of resilience in cases of incest, father-daughter, step-father and step-daughter in the pre-pubber and puberous period among adult women and mothers: How to overcome the traumatisms of an incestuous relationship?
Daniele Lapointe, Laval University, Canada
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom